Cis-regulatory control of the SM50 gene, an early marker of skeletogenic lineage specification in the sea urchin embryo by Makabe, Kazuhiro W. et al.
1957Development 121, 1957-1970 (1995)
Printed in Great Britain © The Company of Biologists Limited 1995
Cis-regulatory control of the SM50 gene, an early marker of skeletogenic
lineage specification in the sea urchin embryo
Kazuhiro W. Makabe*, Carmen V. Kirchhamer, Roy J. Britten and Eric H. Davidson
Division of Biology 156-29, California Institute of Technology, Pasadena, CA 91125, USA
*Present address: Department of Zoology, Faculty of Science, Kyoto University, Kyoto 606, JapanThe SM50 gene encodes a minor matrix protein of the sea
urchin embryo spicule. We carried out a detailed func-
tional analysis of a cis-regulatory region of this gene,
extending 440 bp upstream and 120 bp downstream of the
transcription start site, that had been shown earlier to
confer accurate skeletogenic expression of an injected
expression vector. The distal portion of this fragment
contains elements controlling amplitude of expression,
while the region from - 200 to +105 contains spatial control
elements that position expression accurately in the skeleto-
genic lineages of the embryo. A systematic mutagenesis
analysis of this region revealed four adjacent regulatory
elements, viz two copies of a positively acting sequence
(element D) that are positioned just upstream of the tran-
scription start site; an indispensable spatial control element
(element C) that is positioned downstream of the start site;
and further downstream, a second positively acting
sequence (element A). We then constructed a series of
synthetic expression constructs. These contained oligonu-
cleotides representing normal and mutated versions of
elements D, C, and A, in various combinations. We also
changed the promoter of the SM50 gene from a TATA-less
to a canonical TATA box form, without any effect on
function. Perfect spatial regulation was also produced by a
final series of constructs that consisted entirely of heterol-
ogous enhancers from the CyIIIa gene, the SV40 early
promoter, and synthetic D, C, and A elements. We demon-
strate that element C exercises the primary spatial control
function of the region we analyzed. We term this a ‘locator’
element. This differs from conventional ‘tissue-specific
enhancers’ in that while it is essential for expression, it has
no transcriptional activity on its own, and it requires other,
separable, positive regulatory elements for activity. In the
normal configuration these ancillary positive functions are
mediated by elements A and D. Only positively acting
control elements were observed in the SM50 regulatory
domain throughout this analysis.
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SUMMARYINTRODUCTION
Cis-regulatory target sites encode the recognition elements by
which a gene interprets its spatial position in development.
Here we demonstrate the individual functions of specific target
site sequence elements that are required to generate accurate
transcriptional expression of a gene utilized exclusively in the
skeletogenic lineages of the sea urchin embryo. From a devel-
opmental point of view, the gene we have chosen for this study,
SM50, provides an excellent molecular marker of the
autonomous specification process by which the skeletogenic
lineages are specified, as we discuss below. We discovered that
a synthetic oligonucleotide representing a single short cis-reg-
ulatory site is capable of imposing skeletogenic lineage-
specific expression on an entirely heterologous expression
vector.
In regularly developing sea urchins, the skeletogenic lineages
derive from four polar founder cells, the large micromeres.
These segregate from their non-skeletogenic sister cells, the
small micromeres, at fifth cleavage. Three further divisions ofthese lineages ensue during late cleavage, so that the embryo
now contains 32 skeletogenic precursor cells. After gastrulation
another division of these cells occurs so that the embryo ulti-
mately contains 64 skeletogenic mesenchyme cells (Cameron
et al., 1987; Ruffins and Ettensohn, 1993). At the early blastula
stage, the skeletogenic precursor cells are located symmetri-
cally in the vegetal wall of the embryo, surrounding the descen-
dants of the small micromeres. They are surrounded by the
vegetal plate precursors of the archenteron, with which they are
in close contact. Midway into blastulation the skeletogenic pre-
cursors undergo a stereotypic differentiation process, as a result
of which they acquire mobility, alter their cell surface con-
stituents and properties, and reorganize their cytoskeletal
structure. They then ingress singly into the blastocoel and
assume a mesenchymal character (for review see Davidson,
1986; Ettensohn and Ingersoll, 1992; McClay et al., 1992). At
the early gastrula stage the skeletogenic mesenchyme cells
aggregate around the base of the invaginating archenteron.
Skeletal elements, or spicules, then begin to be secreted, in two
bilateral clusters of skeletogenic cells that form on the oral side
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Fig. 1. Schematic diagrams of injected constructs and efficiency of
expression as monitored by whole-mount in situ hybridization.
Regions of the regulatory domain referred to in the text are indicated
at the top of the figure. Background levels of ectopic expression were
about 2% (0-4% depending on batch of eggs used). Every construct
shown that was expressed significantly over background was
expressed only in cells of the skeletogenic mesenchyme lineages,
i.e., above the average 2% background level. The fraction of
embryos developing from eggs injected with each construct that
expressed CAT DNA is shown immediately to the right of each
colored diagram. Following this is the number of embryos (n) that
constituted the total sample of embryos scored for that construct. The
number of different experiments constituting that sample is indicated
by the batch designations in the right-hand column. Each batch
represents eggs from a single female on a given day. Each individual
experiment, carried out on a single batch of eggs, is indicated by a
capital letter. (A) ∆(- 440), a construct containing the entire
regulatory region between - 440 and +120. This is composed of the
‘distal’ (yellow), ‘proximal’ (green), ‘initiator’ (purple), and ‘plus’
(blue) regions. (B) Constructs used to analyze the proximal region.
Regions that were transversionally mutated are shown in pink. 
(C) Constructs used to analyze the plus region. (D) m(Inr)TATA, a
construct in which the original initiator was replaced by a synthetic
TATA box (T) and a synthetic initiator (red) (see text). The sequence
of the changed region of the gene is shown in Fig. 3(B). 
(E) SV40(DCA), a construct containing the SV40 early region
promoter and synthetic DNA sequences representing the D, C, and A
sequence elements of the original SM50 gene (see text). ‘%
expression’ is the percentage of embryos expressing the CAT
reporter, as observed by whole-mount in situ hybridization in ‡ two
skeletogenic mesenchyme cells (see text).of the embryo. Many genes that are specific to the skeletogenic
process have been cloned (cf. reviews cited above; also Drager
et al., 1989). At present the best known of these genes are
msp130, which encodes a cell surface glycoprotein (Leaf et al.,
1987; Anstrom et al., 1987; Harkey et al., 1992; Kabakoff et
al., 1992), and the SM30 (George et al., 1991; Akasaka et al.,
1994) and SM50 genes (Benson et al., 1987; Sucov et al., 1987,
1988; Katoh-Fukui et al., 1991). Both SM30 and SM50 encode
proteins of the matrix within which the mineral elements of the
skeletal structures are embedded. SM50 is of particular interest
as a marker of the initial process by which the skeletogenic
lineages are specified. Its transcripts begin to accumulate in the
skeletogenic precursor cells within only two to three cleavages
after the definitive 5th cleavage segregation of these lineages
(Benson et al., 1987; Killian and Wilt, 1989). This is almost a
whole day before the process of skeletogenesis per se begins to
take place in the species with which this work was carried out,
Strongylocentrotus purpuratus, and is also far in advance of any
of the blastula-stage differentiation events that lead to ingres-
sion and expression of mesenchymal functions. We regard
SM50 gene expression as an early marker of skeletogenic
lineage specification.
Specification of the skeletogenic founder cells in regularly
developing sea urchins is, by all available tests, an autonomous
process (Davidson, 1989, 1990; McClay et al., 1992). No
immediate intercellular interactions are required for this spec-
ification to occur. Thus, once the skeletogenic micromeres
have formed, they can be transplanted to ectopic locations in
the embryo, whence their progeny ingress and carry out skele-
togenesis, irrespective of their new location (Hörstadius, 1939;
reviewed by Davidson, 1989). These cells are even unable to
produce progeny that express any other differentiated fates, in
contrast to all other blastomeres of the cleavage-stage sea
urchin embryo (excepting their small micromere sister cells).
Furthermore, as first shown by Okazaki (1975), if placed in
culture, isolated 4th cleavage micromeres will carry out skele-
togenesis in vitro, after undergoing the stereotypic number of
divisions (reviewed by Davidson, 1986, p. 221); the only
requirement is the addition of a small amount of horse serum
to the sea water. The micromeres that harbor the autonomous
potential to give rise to the skeletogenic precursor lineages are
formed by the horizontal 4th cleavage plane, which is posi-
tioned so that they together include only the polar 7.5% of the
cytoplasmic volume of the egg (Ernst et al., 1980). The impli-
cation of this autonomous specification process (Davidson,
1989, 1990) is that the activation of the earliest cohort of genes
expressed exclusively in the skeletogenic lineage might depend
on maternal factors localized at the vegetal pole of the egg.
MATERIALS AND METHODS
Animals and embryos
Adult Strongylocentrotus purpuratus collected along the Southern
California coast were maintained in chilled sea water tables so that
gametes were available year round at the Caltech Kerckhoff Marine
Laboratory (Leahy, 1986). Preparations of gametes, fertilization and
embryo culture were carried out according to standard methods. The
embryos were microinjected as described by McMahon et al. (1985)
with gel-purified, linearized plasmid DNA. Approximately 2500
molecules of the desired plasmid DNA were introduced per embryo,together with a four-fold molar excess of PstI-digested carrier sea
urchin DNA (Franks et al., 1990).
All of the expression constructs used in this work are illustrated
diagrammatically in Figs 1 and 4, to which the reader is referred for
nomenclature used in the following. Constructs ∆(- 200), ∆( - 155) and
∆(- 10) were gel-purified after digestion of ∆( - 440) DNA with HpaII,
AvaII and DdeI, respectively. ∆(- 440) is the same as pB2S•CAT of
Sucov et al. (1988), which contains a BglII-SalI fragment of the
original SM50 gene. Fusions ∆(d), ∆(b), ∆(a) and ∆(ab) were recon-
structed from fragments of pB2S•CAT double digested with AvaII and
DdeI; NsiI and SfuI; SfuI and SalI; and NsiI and SalI, respectively (see
Fig. 3 for sequence; relevant restriction sites in this region of the SM50
gene are indicated in Fig. 1). 
Mutations were introduced in the form of synthetic oligonu-
cleotides. Essentially, the region to be mutated was in each case
replaced by synthetic double-stranded oligonucleotides in which the
sequence had been transversionally changed (i.e., A« C; T« G).
Some oligonucleotides contained flanking restriction enzyme target
sites also present in the SM50 gene so that they could be ligated into
the expression vector. In other cases five-nucleotide tags were built
onto the termini of the oligonucleotides, and complementary tags onto
the termini of other oligonucleotides, for use in constructs bearing
multiple mutated sites (cf. Fig. 1). The exact sequences of the SM50
regulatory domain that were transversionally mutated in this fashion
are indicated in Fig. 3.
Other fusion genes utilized (Fig. 1D,E; and all constructs shown in
Fig. 4) were assembled from vector elements and positive regulatory
elements derived from different genes, together with oligonucleotides
representing natural elements of the SM50 sequence. The sequences
reproduced in these oligonucleotides are indicated as open boxes in
Fig. 3. These oligonucleotides also contained terminal tags to allow
their insertion into the vector or ligation to contiguous oligonu-
cleotides. The sequence of the plus-strand oligonucleotide used for
region D was cgcgCCAGGGTTACGacaccct; for region C,
1959Cis-regulatory control of the SM50 genecgaggTGGTAGTCGTGAATGCATCGATCTCcgggtctag; and for
region A, atcccAAAGTCTAGTGAGATCGCAACACATTTGA-
GAAGCAg. The minus strand of the region A oligonucleotide, which
is not shown here, contained a SalI site at its 5¢ end. The elements toSV40 early p
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1960 K. W. Makabe and othersexpression vector as above, the SV40 early promoter, and two
fragments from the CyIIIa gene containing the distal SpGCF1 (P8)
cluster of enhancer sites (Thézé et al., 1990; Zeller et al., 1995), and
the sites at which the positively acting factors SpCTF1 (P4), SpTCF1
(P5), and SpOct1 (P3B) bind (reviewed by Coffman and Davidson,
1992). These three sites were obtained on a single restriction fragment
from a deletion mutant of CyIIIa•CAT which lacks the negatively
acting P3A2 target site (unpublished experiments). RTB-1 also
includes a synthetic polylinker, PL1/2, containing ApaI, NheI, AscI,
Acc65I, and BamHI sites, positioned at the 5¢ side of the CAT coding
sequence. A second synthetic polylinker, PL3/4, that includes HindIII,
XhoI, ApaI, PstI, SphI, BglII, BsiWI, MluI, XbaI, EagI, EcoRV, and
SalI sites, was positioned at the 5¢ end of the SpGCF1 site cluster.
Synthetic TATA and initiator box elements were also used in some
constructs. Based on consensus compilations (Kaufmann and Smale,
1994) the oligonucleotides bearing these included the sequences
CATATTA, and ACACC, respectively. These sequences were built
into a D¢ or D oligonucleotide (cf. Fig. 3) and ligated together with
other oligonucleotides and/or the vector, as required, by the same
approach as above. In the synthetic TATA box constructs the junction
point between the natural SM50 sequence and the TATA-D oligonu-
cleotide was after the T at - 55 of the natural sequence (Fig. 3).
Whole-mount in situ hybridization and CAT assay
The whole-mount in situ hybridization protocol used here is based on
the method described by Ransick et al. (1993). However, the
procedure was slightly modified by the use of Streck Fixative (Streck
Laboratories Inc., NE). Fixation was carried out overnight at 4°C,
followed by a brief wash in 50 mM Tris buffered-saline, containing
0.1% Tween 20. The proteinase K treatment and post-fixation
procedure of Ransick et al. (1993) were omitted. CAT assays were
carried out according to Seed and Sheen (1988). 
RESULTS
Temporal and spatial expression of ∆(- 440), an
SM50•CAT fusion gene
Spatially accurate embryonic expression of exogenous
SM50•CAT fusion constructs was demonstrated earlier by
Sucov et al. (1988). Their starting construct, which was
expressed exclusively in the skeletogenic mesenchyme cells of
mesenchyme blastula-stage embryos, included SM50
sequences extending from - 2200 downstream to +120, with
respect to the transcription start site. Expression was assayed
by radioactive in situ hybridizations carried out on serially
sectioned samples. No change in level or locus of expression
was observed when the upstream sequence was deleted down
to - 440, but further deletions sharply decreased expression
(Sucov et al., 1988). This evidence provided the starting point
for our present experiments. As we describe below, the
minimal SM50 regulatory domain defined by Sucov et al.
(1988) contains a number of functionally significant sequence
elements, and their further analysis required the use of fine-
scale deletions, mutations, and a variety of synthetic con-
structs. Fig. 1 displays a series of mutationally altered
SM50•CAT constructs that we injected into zygotes and
analyzed quantitatively for expression during embryogenesis.
We had the advantage in this work of more sensitive methods
of analysis than were available to Sucov et al. (1988), viz the
whole-mount in situ hybridization procedure of Ransick et al.
(1993; slightly modified, as described in Materials and
Methods, by the use of a different fixative).The construct shown at the top of Fig. 1, ∆(- 440), serves as
the control for the remaining constructs. In Fig. 1 the regula-
tory sequence included in ∆( - 440) is divided into four color-
coded subregions, to which we refer in the following. These
are the ‘distal’ region (- 440 to - 200), shown in yellow; the
‘proximal’ region (- 200 to - 10), shown in green; the ‘initiator’
region (- 10 to +10) shown in purple; and the ‘plus’ region (+10
to +120) shown in blue. There may well exist additional cis-
regulatory sequence upstream of - 440 in the native SM50 gene,
particularly since we have not investigated requirements for
larval or post-metamorphosis expression of this gene, which is
utilized in adult test and spine-producing cells as well as in
embryonic skeletogenic cells (Richardson et al., 1989). With
respect to embryonic expression, however, we have confirmed
and extended the observations of Sucov et al. (1988) that the
SM50 sequence between - 440 and +120 suffices to generate a
normal pattern of expression. Thus, injected ∆( - 440) is
expressed almost exclusively in skeletogenic mesenchyme
cells. Illustrative embryos in which skeletogenic mesenchyme
expression of ∆(- 440) is visualized by whole-mount in situ
hybridization are shown in Fig. 2A1-A3. 
When DNA is injected into sea urchin zygotes it rapidly con-
catenates in the cytoplasm, and the concatenate becomes stably
incorporated in a blastomere nucleus, in most cases at 2nd, 3rd,
or 4th cleavage, though later incorporations also occur
(McMahon et al., 1985; Flytzanis et al., 1985; Hough-Evans et
al., 1988; Livant et al., 1991). Thereafter the exogenous DNA
replicates together with the host cell DNA (Franks et al., 1988;
Livant et al., 1991), and is thus present in all of the cells of the
clone to which the blastomere initially incorporating it gives
rise. The transcriptional capacity of injected constructs is
amplified by this process, because the exogenous DNA in each
embryonic cell consists of a replica of the original concatenate.
Thus as we found earlier (McMahon et al., 1985; Flytzanis et
al., 1985; Livant et al., 1988), each cell bearing the exogenous
DNA typically contains a sufficient number of copies of the
introduced regulatory sequences to sequester a significant
fraction of the transcription factors that service it. This means
that the observed expression is contributed by many copies of
the injected gene.
The mosaic incorporation pattern that results can be
observed in Fig. 2A, for example. Eight of the 32 skeletogenic
mesenchyme cells in the embryo at this stage are stained (these
cannot all be distinguished clearly in the plane of focus shown),
indicating that the incorporation occurred either in one of the
first four blastomeres, in a vegetal 3rd-cleavage blastomere, or
in a 4th-cleavage micromere, but not later. Embryos were con-
sidered positively stained only if two or more cells displayed
the blue reaction product, and if the embryos were morpho-
logically normal. In our experience the single stained cells that
are occasionally observed usually indicate unstable or transient
exogenous DNA that will disappear later in development, and
that is often ectopically expressed irrespective of the construct
injected. Single stained cells can also be produced as a result
of experimental damage or abnormal developmental process
that causes cells to delaminate from the ectoderm and fall into
the blastocoel. The top line of data in Fig. 1 shows that by these
criteria ∆( - 440) was expressed in an average of close to 25%
of embryos, based on examination of almost a thousand
embryos belonging to 19 different batches of eggs (each batch
is derived from a single female). Some batches were more
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Table 1. CAT enzyme activity in transgenic embryos
bearing SM50•CAT mutants
CAT activity normalized to value obtained for ∆( - 440) at 48 hr
Constructs 21 hours pf 30 hours pf 48 hours pf
∆(- 440) 18.2 86.4 100.0
∆( - 200) — 25.9 45.8
SV40(DCA) 2.7 17.3 15.8
Each value represents the average of two or more samples of 100 injected
eggs, except for the 21 hour SV40(DCA) sample, which consisted of 700
injected eggs.  pf, post-fertilization.active than others, and in these as much as 30-35% of embryos
displayed labeled mesenchyme cells. The majority of batches
expressed in about 24-28% of embryos. However, these values
are all about two-fold lower than what would be expected on
a purely random basis, judging from results obtained with con-
structs that are expressed in ectodermal or vegetal plate terri-
tories, in which 60-80% of embryos commonly express the
injected constructs (C.-H. Yuh, C. Kirchhamer, E. Davidson,
unpublished data). It follows that there is probably a bias
against incorporation into skeletogenic precursors, i.e., the 4th
or 5th cleavage micromeres. Such a bias might arise simply
from the reduced chance these cells have of inheriting the
exogenous DNA concatenate because of the disproportionately
small fraction of zygote cytoplasm they inherit, or perhaps
because of their delayed cleavage. An indication of a bias
toward later incorporation than seen with other territories is
that the average number of stained cells per positive embryo
was, for ∆( - 440), only three to four (again there was batch
variation in this statistic). We note that Sucov et al. (1988)
reported a similar result, about five cells labeled per positive
embryo, based on a very much smaller sample.
Spatial expression of ∆(- 440) is quite accurate, in that <2%
of injected embryos ever displayed any ectopic expression, i.e.,
expression other than in skeletogenic mesenchyme. ∆( - 440)
also contains cis-regulatory sites that mediate the temporal
activation of the reporter as development proceeds. Transcripts
of the endogenous SM50 gene accumulate sharply during
development, from a few per skeletogenic precursor cell in late
cleavage to 100-200 per cell from the mesenchyme blastula
stage onward (Killian and Wilt, 1989). Measurements of the
relative transcription rate by the run-off method also show that
the SM50 gene is transcriptionally activated by mesenchyme
blastula stage (Killian and Wilt, 1989), but no comparisons
between mesenchyme blastula and later stages are available.
Table 1 shows a several-fold increase in CAT enzyme content
in embryos expressing ∆(- 440) between mesenchyme blastula
and 30 hour (early gastrula) or 48 hour (late gastrula) stages.
The same fraction of embryos was observed to be expressing
∆( - 440) at 21 hours, as at the 48 hour late gastrula stage for
which data are recorded in Fig. 1. Therefore the number of
expressing embryos at 48 hours is not limited by the sensitiv-
ity of the in situ hybridization (see also below). The develop-
mental increase in CAT levels between mesenchyme blastula
and gastrula stages requires a proportionately increased rate of
transcription from ∆(- 440) over this period, since both CAT
mRNA and CAT enzyme protein are unstable in sea urchin
embryos. Their half-lives were estimated earlier at ≤40 minutes
(Flytzanis et al., 1987). 
The distal region of ∆(- 440) affects the level of
expression
Preliminary experiments of Sucov (1989) showed that
deletions extending proximally of - 440 depress the level of
expression of SM50•CAT constructs. Table 1 demonstrates that
deletion of the distal region (construct ∆(- 200) in Fig. 1) in
fact results in a two- to three-fold decrease in CAT expression,
as monitored at early and late gastrula stages. This, however,
does not bring the level of CAT expression down near the limit
of detection of whole-mount in situ hybridization, since, as
shown at the right side of Fig. 1, about the same fraction of
embryos bearing the ∆(- 200) construct score as positive as ofembryos bearing ∆(- 440). Expression of ∆( - 200) remains
entirely confined to skeletogenic mesenchyme cells, as illus-
trated in the embryo shown in Fig. 2B1,2. Thus the only
function that we observed for the distal region is quantitative.
We did not explore further the distal region in this work, and
thus it remains undetermined whether its positive function is
specific to skeletogenic mesenchyme lineages. However, a
clear conclusion from the ∆( - 200) experiments can be drawn,
viz that skeletogenic mesenchyme-specific regulatory elements
are present in the SM50 sequence that lies between - 200 and
+120.
Two copies of an important regulatory sequence,
the ‘D-repeat’, are present in the proximal region
A further deletion to - 155 gave essentially the same result as
did ∆(- 200), but when the sequences inward to - 10 were also
deleted, expression dropped precipitously (Fig. 1; ∆(- 10)).
Less than 10% of embryos now expressed CAT DNA at a level
sufficient for detection by whole-mount in situ hybridization.
Nonetheless the remaining expression was still confined to the
skeletogenic mesenchyme. Therefore cis-regulatory elements
specifying the territorial spatial function of the SM50 gene
must exist still further downstream, between - 10 and +120.
The positive regulatory function indicated by this experi-
ment for the sequence between - 155 and - 10 (for convenience
this region is labeled ‘d’ at the top of Fig. 1) cannot be substi-
tuted by the positive function resident in the distal region. Thus
expression of construct ∆(d), which consists of ∆(- 440) minus
region d, is depressed as much as expression of ∆(- 10) (see
Fig. 1). To identify the responsible sequences we generated the
twelve mutations labeled m(prox1) to m(prox1235) in Fig. 1.
These were assembled from a series of overlapping synthetic
oligonucleotides, as described in Materials and Methods. The
exact sequences that were mutated by this means to produce
the constructs shown in Fig. 1 are indicated in Fig. 3. As sum-
marized in Fig. 1B, none of the single block mutations (i.e.,
m(prox1) to m(prox5)) affected expression as severely as
observed with ∆(- 10) or ∆(d), and mutants m(prox1) to
m(prox3) were expressed as well as the control ∆(- 440). Again
in these experiments expression was always confined to cells
of the skeletogenic mesenchyme lineages. Double, triple and
quadruple block mutants were then tested. We found (Fig. 1B)
that only in mutants in which the sequence of regions 4 and/or
5 were altered was the percentage of positive embryos signif-
icantly depressed (i.e., m(prox4), m(prox345), m(prox45),
m(prox1234), and m(prox5), m(prox345), though not
m(prox1235)). This result indicated that a strong positively
acting element is present in both subregions 4 and 5. When
both of these subregions are mutated (e.g. in m(prox4,5),
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Fig. 2. Illustrative whole-mount in situ hybridizations of embryos bearing various expression constructs, indicated in each panel. Injected
zygotes were cultured for 24 hours (mesenchyme blastula stage embryos) or 48 hours (late gastrula stage embryos). The blue staining is seen
only in skeletogenic mesenchyme cells (the dark peripheral region observed in Fig. 2(E1) is an optical shadow rather than bona fide staining).
Fig. A1, A2, B1, and F2 are photographs that were scanned to convert them to digital images; the remainder of the panels display digital
images that were generated on a Roche Imaging Camera (ProgRes 3012) mounted on a Zeiss Axioskop. The figure was printed on a Nikon CP-
3000 printer.
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Fig. 3. Sequences of regions of the SM50 regulatory domains that
were deleted or mutated, or that were represented by synthetic
double-stranded oligonucleotides in expression vectors described in
Figs 1 and 4. (A) Sequence of SM50 regulatory domain from - 200 to
+120. The final twelve nucleotides of this sequence encode the first
four amino acids of the SM50 protein, including the initial
methionine. Exact endpoints of the deletion mutants shown in Fig. 1
are shown by triangles. Transversionally mutated regions are
bracketed, with the names of the mutated sequences below each
bracket. The D repeats in the proximal region (prox) are shown by a
pair of horizontal arrows. The initiator region (Inr) that was replaced
in the m(Inr)TATA construct is indicated by a dashed underline. An
oligonucleotide, D¢ , that was used in the m(Inr)TATA construct, and
oligonucleotides that constituted the synthetic D, C, and A elements
used in the constructs of Fig. 4 are shown by open horizontal
rectangles beneath the respective sequences. Note that the specific D,
C, and A sequence elements shown here are not identical to any of
the colored regions denoted by a-d at the top of Fig. 1. (B) Sequence
of a changed portion of the SM50 gene in the m(Inr)TATA construct.
Capital letters represent the original sequence from the SM50 gene,
and lower case letters the introduced sequence where it differs from
the native sequence (see A). Numbers represent positions on the
original sequence as in A. The TATA sequence is boxed, and the
new initiator sequence is underlined. (C) Sequence of the initiator
and plus regions of the SM50-TATA(DCA) construct. Capital letters
represent the original sequences from the SM50 gene, that were
transversionally changed in the mutants shown in Fig. 4A. The
introduced TATA box and initiator sequences are indicated as above.
The MluI and SalI sites that were used for the construction of SM50-
TATA(DCA) from m(Inr)TATA are indicated. Spacer regions
containing restriction sites R1 and R2 are shown by rectangles.expression is most severely affected, approaching the low level
observed when the whole of region d is deleted. Another
mutation, in which the sequence lying between subregions 4
and 5 was changed (m(prox123J); J, junction sequence) was
expressed at the control level. It follows that subregions 4 and
5 may each include a target site for a positively acting factor,
separated by the non-essential intervening J sequence (see Fig.
3). Subregions 4 and 5 apparently both contribute to the overall
positive function of the proximal region. In context, subregion
4 might be the more essential, since m(prox1234) displays a
depressed level of expression, while m(prox1235) expresses
normally.
Fig. 3 shows that subregions 4 and 5 in fact both contain, on
either side of the J sequence subelement, one occurrence of the
short, directly repeated sequence AGGGTT. These sequences
are labeled ‘D(4) repeat’ and ‘D(5) repeat’ in Fig. 3A. To test
the proposition that the D repeat is responsible for the regula-
tory function of the proximal region revealed in these experi-
ments, we constructed a synthetic oligonucleotide consisting
of three copies of the sequence labeled D(4) in Fig. 3A (this
includes two flanking nucleotides on the 5¢ end of the D(4)
repeat and three additional nucleotides on the 3¢ end; these
differ between D(4) and D(5)). The synthetic sequence was then
inserted into the ∆(d) construct (see Fig. 1, Construct 3xD), and
injected into eggs. This construct behaved exactly as did the
CCGGCTAGGT
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(SalI)control ∆(- 440), producing skeletogenic mesenchyme-specific
expression in 27.4% of experimental embryos. An example is
shown in Fig. 2C. The synthetic D(4) sequences thus account
completely for the function of the proximal region of ∆(- 440).
Regulatory elements in the plus region of the SM50
regulatory domain
A similar analysis of the ‘plus’ region was carried out next.
Results from the initial three constructs, shown diagrammati-
cally in Fig. 1C as ∆(b), ∆(c) and ∆(ab), suggested that there
are at least two subregions downstream of the transcription
start site that are individually required for full expression, and
that in their combined absence the construct is dead. We then
built and tested the series of block mutations shown in Fig. 1C
(see Fig. 3A for exact sequences), viz constructs m(plus1) to
m(plus8). Mutations of a sequence extending from +10 to +30
entirely obliterated expression (construct m(plus1), while
mutation of the adjacent seven nucleotides (construct m(plus2)
depressed expression. In the following we designate the
combined sequence that was mutated in these two constructs
(i.e., +13 to +37) as region C. At least a major fraction of this
sequence is absolutely required for SM50 fusion gene
expression.
Proceeding downstream, the regions mutated in constructs
m(plus3) and m(plus4), i.e., from +40 to +60 (Fig. 3), are
apparently not essential. Thus as summarized in Fig. 1C, these
constructs were expressed at normal levels, i.e., in about 24-
30% of injected embryos. However, mutations in the region
+60 to +103 all displayed reduced expression. This is shown
in Fig. 1C for constructs m(plus5) to m(plus8). The sequence
from +60 to +103 is designated region A in the following; like
1964 K. W. Makabe and othersregion D this sequence acts positively, but neither deletion nor
mutation of region A affects the nearly perfect localization of
the residual expression in skeletogenic mesenchyme cells.
Normal expression of the construct shown at the bottom of Fig.
1C, m(plus/mid), confirms that regions C and A alone can sub-
stitute for the whole plus region, and also that the sequence
between the C and A elements is dispensable.
By process of elimination it would appear from these exper-
iments that the sequence element conferring skeletal mes-
enchyme-specific spatial expression must be either region C or
the initiator region. All other deletions and mutations so far
reviewed, i.e., the distal region deletions, the mutations that
identified the D region of the proximal domain, and the A
region mutations of the plus domain, preserve skeletogenic
mesenchyme specificity. This test could of course not be
applied to the mutation defining the C region, because without
the C sequence no expression that can be observed by whole-
mount in situ hybridization is obtained at all.
The initiator sequence is not required for
skeletogenic mesenchyme specificity
The SM50 promoter lacks a TATA box (Sucov et al., 1988),
and instead belongs to the class of genes that utilize only an
initiator sequence. This is the element that in a TATA-less
promoter determines the transcription start site by serving as
the assembly point for the TFIID complex (Kaufmann and
Smale, 1994). To determine if the region in SM50 that extends
from - 10 to +10 with respect to the transcription start site
might also be required for the spatial regulation of SM50•CAT
constructs, we rebuilt this region of the gene, replacing it with
a synthetic oligonucleotide encoding a consensus initiator site
(Kaufmann and Smale, 1994). As shown in Fig. 3B, the natural
SM50 sequence and the sequence including the initiator
element (ACACC) differ completely for the 10 bp following
the SM50 transcriptional initiation site (+1). A consensus
TATA box sequence was also inserted immediately upstream
of a synthetic D repeat element at position - 25 (Fig. 3B). The
SM50 sequence was thus changed into that of a typical TATA
box-containing gene. The expression vector carrying this alter-
ation, m(inr)TATA (Fig. 1D), was injected into eggs and its
expression assessed by whole-mount in situ hybridization.
Expression was again observed only in skeletogenic mes-
enchyme, as illustrated in Fig. 2D. Furthermore, the efficiency
with which m(Inr)TATA was expressed (21.0%) is only a few
percent below that of the control ∆( - 440). The original initiator
sequence is therefore not the locus of spatial specificity in con-
structs such as ∆(- 10) or m(plus/mid) (cf. Fig. 1).
To confirm that the D, C, and A elements function as well
with the TATA-containing construct as with the natural
initiation sequence, we carried out the experiments summa-
rized in Fig. 4A. Here the entire sequence of ∆(- 440) from 
- 55 to +120, was replaced with synthetic DNA. As Fig. 3
indicates, - 55 is the position at which the D repeats of the
proximal region begin in the natural SM50 sequence. A 7 bp
CATATTA sequence was inserted at this point, followed by
the synthetic D sequence, and 25 bp from the TATA sequence,
the initiator sequence (ACACC) was inserted, together with a
restriction site linker to join it to the following C sequence, as
above. The sequence of the junctional region of this vector,
SM50•TATA, is shown in Fig. 3C. In it were mounted either
normal, or transversionally mutated D, C, and A sequenceelements in various combinations, as shown in Fig. 4A. When
normal D, C, and A sequences were present, the construct func-
tioned exactly as does ∆( - 440), producing skeletogenic mes-
enchyme-specific expression in about 29% of experimental
embryos. This result has two consequences. First, it proves that
there is no detectable difference in transcriptional regulatory
function whether the gene does or does not contain a TATA
box sequence; second, it eliminates any possibility that
sequence other than that included in the synthetic D, C, and A
oligonucleotides is required for the regulatory function we
observe. The further experiments, detailed in Fig. 4A,
reproduce, with these entirely synthetic sequence elements, the
same relationships seen in Fig. 1C. Thus, without a normal C
sequence, expression is reduced to the level of the ectopic
background expression, about 2% (this is shown by construct
SM50•TATA(DA)). Addition of either the A or D oligonu-
cleotide (SM50•TATA(DC) and SM50•TATA(AC)) to C
partially restores expression, though D is more effective than
A. Without either D or A, the C sequence element alone is not
functional (SM50•TATA(C)). Thus it appears that for the C
sequence element to promote expression, an ancillary positive
function mediated by the D and/or A sequences is required.
This is so even though the SM50•TATA constructs all include
the distal region enhancer.
Regulatory function of synthetic D, C, and A
elements in a vector composed entirely of
sequences from other genes
We next examined the function of synthetic D, C, and A
elements in vectors that contained no other SM50 sequence.
The construct SV40(DCA) (Fig. 1E) consists solely of the 200
bp enhancer-less SV40 early region promoter, which includes
a TATA box and six Sp1 sites (Khoury and Gruss, 1983;
Briggs et al., 1986), plus the synthetic D, C, and A oligonu-
cleotides. While several transcription factors have been
isolated from sea urchin embryo nuclear extracts that bind GC-
rich target sites (Zeller et al., 1995; Hapgood and Patterson,
1994; Xiang et al., 1991) a sea urchin Sp1 factor has so far not
been identified. Three of the Sp1 sites in the SV40 element,
however, are also target sites for the sea urchin SpGCF1 factor
(Zeller et al., 1995), which in context of various other factors
functions as a positively acting regulator. Nonetheless, a vector
consisting only of SV40 and the CAT reporter (SV40•CAT) has
very little activity. The SV40(DCA) construct does express,
however, and its expression is confined to skeletogenic mes-
enchyme. A quantitative comparison of CAT enzyme activity
in embryos bearing SV40(DCA) and ∆( - 440) is shown in Table
2. While the level of SV40(DCA) expression is only 16% of
that produced by ∆(- 440), it is still sufficient to produce sig-
nificant whole-mount in situ hybridization signals in about
18% of the embryos. An embryo bearing SV40(DCA) is shown
in Fig. 2E1,2. 
In the course of the foregoing experiments we never
observed significant ectopic expression; that is, none of the
deletions or mutations we studied provided even a hint of the
existence of negative spatial regulatory functions in the SM50
cis-control system. The fact that SV40(DCA) is also expressed
specifically in skeletogenic mesenchyme confirms that the
spatial regulatory function carried out by the D, C, and A
sequence elements is entirely positive. There are no other
SM50 sequences present in this construct. Therefore there is no
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Fig. 4. Schematic diagram of injected constructs and the efficiency of their expression, as monitored by whole-mount in situ hybridization.
Symbolism is as in Figs 1 and 3. The stippled regions in each construct indicate oligonucleotides representing the transversionally mutated
natural sequence. (A) Constructs including one to three of the D, C, and A elements in context of the SM50-TATA vector. The synthetic TATA
box is located at - 55 (T), or - 22 with respect to the beginning of the introduced initiator sequence. The exact sequence of this region is shown
in Fig. 3C. (B,C) Constructs including combinations of normal and mutated D, C, and A elements in the context provided by the RTB-1 vector.
The synthetic A, C, D or mutated A, C, D elements were inserted between the SV40 promoter and the CAT gene (B), or into the most upstream
position in a reversed orientation (C). Values in B represent summed data from three independent experiments which produced almost identical
results. In the RTB-1 control group the 5.8% of embryos staining were in approximately equal parts stained in mesenchyme, in ectoderm, and
in both. Thus the same small amount of ectopic (i.e., ectoderm) staining was also observed in the RTB-1(C) samples; i.e., it was not enhanced
as was the mesenchyme staining by the addition of the C element. However about 10% of embryos bearing RTB-1(C) displayed some
ectoderm staining, suggesting that the combination of ‘A’ factor with the RTB-1 enhancers produces a weak ectoderm localizing activity.possibility that the accurate expression that it produces could
be due to sequences outside of D, C and A that mediate
negative control functions which we somehow missed in the
foregoing experiments.The control system isolated in SV40(DCA) also mediates the
temporal activation of transcription seen earlier with ∆(- 440).
Thus as Table 1 shows, the CAT enzyme content of embryos
expressing this construct is 5- to 7-fold higher at gastrula stage
1966 K. W. Makabe and others
Table 2. CAT enzyme activity in embryos bearing various
heterologous SM50 expression constructs
Construct Enzyme units/embryo· 10- 5*
SM50∆(- 440) 1.8
SV40(DCA) 0.3
RTB-1(DCA) 2.4
RTB-1(D) not detected
RTB-(C) 0.3
RTB-1(A) not detected
RTB-1(DC) 1.5
RTB-1(DA) not detected
RTB-1(CA) 0.7
*Each value represents the average of two independent samples, of 100
injected eggs per sample.than at 21 hour mesenchyme blastula stage. Note that at all
three stages there is about a six-fold ratio of expression of ∆(-
440) to SV40(DCA). This suggests that the change in
expression that we observe over this developmental period is
entirely due to the DCA element, and not to other regions of
∆( - 440), while the absolute level of expression at each stage
does depend on the positive elements located elsewhere in the
regulatory domain. From the experiments reviewed above,
these positive elements are likely to be the second D element
that is present in ∆(- 440), and the distal region element.
To compensate for the relatively weak expression of
SV40(DCA) we added to it two DNA fragments bearing posi-
tively acting enhancers from the regulatory domain of the
CyIIIa gene, which is normally expressed only in the aboral
ectoderm of the embryo. These are, a distal region of CyIIIa
bearing a cluster of the SpGCF1 sites, and a second fragment
bearing sites for three different positively acting factors,
SpOct1, SpCTF1, and SpTEF1 (Thézé et al., 1990; Calzone et
al., 1988; Coffman and Davidson, 1992; C. Kirchhamer, J.
Xian and E. Davidson, unpublished data). None of these reg-
ulatory factors are believed to convey any territorial spatial
regulatory information or to be spatially confined in their
activity. These positive regulatory elements were associated
with SV40(DCA) with the use of an inserted polylinker (see
Materials and Methods). The resulting construct, RTB-1(DCA),
expressed almost as well as ∆(- 440), as shown in Table 2.
Expression was observed in 21% of experimental embryos
(Fig. 4B), and was again specific to the skeletogenic mes-
enchyme. In the absence of the DCA insert, RTB-1 produces
only a low level of (mainly ectodermal) expression in a few
percent of embryos developing from injected eggs. When the
synthetic DCA insert was reversed in orientation, and posi-
tioned at the distal end of the RTB-1 construct (see Fig. 4C),
no activity above that of RTB-1 alone was observed.
Finally we sought to determine whether the D, C, or A
element alone could confer spatial specificity, based on the
theory that RTB-1 might include sufficient positive enhancer
functions to display the spatial specificity of any added element
if it had one. The experiments summarized in Fig. 4B provide
the answer. RTB-1(C), in which the only non-mutated SM50
sequence is a single C element, is expressed specifically in
skeletogenic mesenchyme, in 14.6% of embryos. Examples of
such embryos are shown in Fig. 2F1-3. In the absence of
element C no significant expression at all is observed (RTB-
1(DA), RTB-1(D), RTB-1(A); see Table 2, and Fig. 4B). Thus,
the role of elements A and D in RTB-1(DCA) is merely to
increase the activity of element C, and together with element
C each of these is individually capable of increasing the level
of expression (Table 2; constructs RTB-1(DC) and RTB-
1(CA)). These experiments demonstrate that element C alone
is able to convey spatial specificity for transcriptional
expression in the skeletal mesenchyme lineages.
DISCUSSION
Functions of the D, C, and A cis-regulatory elements
The region of the SM50 regulatory domain that most of this
study has focused on extends from - 55 to about +105 with
respect to the transcriptional start site. This sequence is capableof directing skeletogenic mesenchyme-specific expression of a
reporter gene, at a level of activity that is only a few-fold below
that of any of the longer constructs studied by Sucov et al.
(1988) or ourselves. We show that the essential elements
within this region are the directly repeated D sequences just
upstream of the initiator element; the C element, which lies
within the sequence from +12 to +37, and the A element, which
lies within the region from +71 to +105. Thus, the C and A
sequence elements are included in the transcribed leader
sequence of the gene, and the translational initiation site occurs
only a few bp beyond the end of the A regulatory element. We
have established the functions of the D, C, and A elements by
the use of synthetic oligonucleotides that represent either
normal or mutated variants of the sequences. These were used
to rebuild the - 55 to +105 region of the expression constructs
in a variety of combinations, in the context of both the normal
upstream SM50 sequence and of an entirely heterologous
expression vector that contained no SM50 sequences other than
the synthetic D, C, and A elements. In addition, we altered the
promoter of the SM50 gene from a TATA-less to a TATA-box
conformation by insertion of canonical TATA and initiator
sequences, and we showed that this transformation has no
effect whatsoever on the functions mediated by the D, C, and
A sequence elements.
The C element is the single irreplaceable regulatory sequence
of the minimal, skeletogenic lineage-specific cis-control system
extending from - 155 to +105. It is the only one of the three
SM50 elements which is alone capable of directing expression
to skeletogenic mesenchyme cells, provided that the vector
contains other elements that serve as enhancers. Entirely het-
erologous enhancers can perform this function, as shown by the
experiments with the heterologous RTB-1 vector (Fig. 4B and
Table 2). The RTB-1 enhancers cannot be skeletogenic mes-
enchyme-specific, since they derive from the CyIIIa gene, in
which they promote expression in the aboral ectoderm. In the
natural SM50 gene the A and D sequence elements provide the
ancillary enhancer functions that the C element requires for
activity; the A and D elements are dispensable only if other pos-
itively acting elements are provided (compare in Fig. 4, SM50-
TATA(C) with RTB-1(C)). The measurements in Table 2,
combined with the prior evidence obtained with specific
mutations of D and/or A, show that both of these elements can
work with C, and that each can function independently of the
other. C is also the only element mutation which completely
kills the ability of SM50 constructs to express. Although in the
natural SM50 sequence the C element lies immediately adjacent
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Thus, in the RTB-1 series of constructs the C element is
separated from the initiator sequence by almost 100 bp of SV40
sequence, plus the length of the synthetic normal or mutated D
sequence element, plus a linker added to provide convenient
restriction sites, i.e., by about 130 bp. Furthermore, in the SM50-
TATA and RTB-1 constructs the D element is downstream of the
initiator site, and is present only singly, while in the normal gene
there are two copies of D upstream of the site of transcriptional
initiation. Similarly, the A element in these constructs is
adjacent to C, except for a linker sequence, while in the normal
alignment it is separated from C by about 30 nonessential base
pairs. Thus, there is clearly some flexibility in the range of
spatial relations among these elements that remain permissive
for function, as well as in their positions with respect to the
assembly point for the basal transcription apparatus.
The C element must bind a transcription factor that is present
or is functionally active only in skeletogenic mesenchyme
lineages, or it could bind a generally present factor that in turn
binds a lineage-specific co-factor. The C element in any case
serves as the central regulatory information processor, by
means of which the SM50 gene is instructed that it is in a skele-
togenic precursor cell. It is not by itself a ‘tissue-specific
enhancer’ since it is completely inactive in the absence of other
enhancer elements. We cannot exclude the possibility that the
proteins interacting with the D and A elements are also present
or functionally active only in skeletogenic mesenchyme cells,
but our experiments clearly show that they need not be. It is
unlikely that the C element is a binding site for a repressor that
in skeletogenic mesenchyme cells is replaced by an activator,
while elsewhere in the embryo the repressor serves to keep the
SM50 gene off. Were this the case, constructs such as RTB-
1(DA), in which the C element is mutated, would be expected
to display enhanced ectopic expression; instead all constructs
lacking a C element express very poorly, if at all.
The C sequence as a ‘locator’ element
It is curious that the C element can function with entirely het-
erologous enhancers as well as with its own natural retainers,
A and D. This makes the idea that the binding of the C proteins
serves as a focus for cooperative binding of the ancillary
enhancer proteins less likely. An interesting speculation that
satisfies our observations is that the lineage-specific protein
that binds the C element (or its enhancer-specific co-factor)
interacts directly with the basal transcription apparatus. Its
function would be to enable or cause the basal transcription
apparatus to respond to a range of enhancers, which may be
present in several spatial domains of the embryo. That is, a
corollary of this idea is that the basal transcription apparatus is
not active in mediating upstream enhancer functions in the
absence of a signal from the factor binding to the C sequence
element (or from a cofactor bound in turn to the C factor). Thus
the powerful CyIIIa elements that are included in the RTB-1
construct are almost inactive in the absence of the C element,
since by itself this vector produces only very low levels of
expression, none of which is in the skeletogenic mesenchyme.
In short, we propose that the primary spatial specificity of the
SM50 gene may be determined by a ‘locator’ element, which
acts as an obligatory facilitator of the transcriptional enhance-
ment functions of other DNA binding factors (see Fig. 5). This
may not be an uncommon mechanism in regulatory systemsthat control spatial expression during development. For
example, expression of the Drosophila Adh gene in the fat body
depends on a cis-element located near the transcription start
site, that like the SM50 C-element confers responsiveness to
more distant enhancers, though in their absence it fails to
promote transcription (Fischer and Maniatis, 1988).
Overall organization of the SM50 regulatory domain
Our knowledge of the functional significance of the sequence
upstream of - 55 is limited. There do not appear to exist any
additional transcriptional control elements in the region
beyond the two D sequence elements (i.e., from - 55 to - 200;
this is shown by the results obtained with the prox series of
mutations summarized in Fig. 1B). Of the distal region we
know only that it includes positively acting elements which if
present mediate several-fold greater activity. However, our
preliminary data indicate that this region contains many closely
packed target sites for DNA binding proteins, and the function
of these interactions remains entirely unexplored. It is
important to note that we have in no way excluded the possi-
bility that the distal region could contain a second skeletogenic
mesenchyme-specific positive control system. 
To our knowledge SM50 differs from every other gene so
far studied that is expressed in a territory-specific manner in
early sea urchin embryos, in that its spatial control system
appears to lack any negative regulatory elements that prevent
expression in other territories. Such elements are easily
detected in gene transfer experiments, since deletions,
mutations, or in vivo competitions affecting interactions at
these elements result in the often spectacular ectopic spatial
expression of test constructs. For example, the CyIIIa gene
(Hough-Evans et al., 1990; Wang et al., 1995; C. Kirchhamer
and E. Davidson, unpublished data), the Spec1 gene (Gan et
al., 1990), the Endo16 gene (C.-H. Yuh and E. Davidson,
unpublished data), and the SM30 gene (T. Frudakis and F. Wilt,
personal communication) are all controlled in part by negative
spatial interactions. We saw no case, in this study, of a
mutation or deletion that produces ectopic expression. Fur-
thermore, we can state unequivocally that the spatial DCA
control system functions only in a positive way. This is a par-
ticularly remarkable feature of the SM50 gene, in that its reg-
ulatory domain contains no less than five sites at which bind a
regulatory factor, SpP3A2, that is almost certainly a negative
regulator of the CyIIIa gene (Zeller et al., 1995; Hough-Evans
et al., 1990). Interactions at the P3A target sites of the CyIIIa
gene repress oral ectoderm expression of this gene (C. Kirch-
hamer and E. Davidson, unpublished data). In the SM50 gene
these sites are at - 354, - 248, - 128, - 114, and - 34. The double
site at - 114 and - 128 has a particularly high affinity for this
factor (Calzone et al., 1991). Yet, as Fig. 1 shows, every one
of these sites was removed by one of the deletions or mutations
tested, singly or in combination, and no ectopic expression was
observed. Note, for example, that the m(prox123J) construct
lacks both the strong double site and the site at - 34, and yet
its expression is quantitatively and spatially normal manner.
The function of the P3A sites in the SM50 gene is another
mystery that remains to be explored. It is still possible that the
SM50 gene has a negative control system in the distal region,
if both a negative functional element, and a positive functional
element, the activity of which it modulates, are located together
within this region. However, we can conclude that no negative
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Fig. 5. Locator function. A speculative role for the factor binding the
C sequence element in the SM50 gene. E1 and E2 are enhancer
proteins binding upstream regions of the cis-regulatory DNA (curved
line); the basal transcription apparatus (TFIID-C), symbolized
simply as a rectangle, indicates the holo-TFIID complex, including
TBP and the TAF co-factors. A locator target sequence element (LE)
is shown downstream of the TFIID complex, because that is the
position of the C target site in the SM50 gene. However, we show
(see text) that this site may be either almost adjacent to the
transcription initiation site or >100 bp downstream and still function,
and thus it might also operate if placed immediately upstream of the
start site. In (A), the regulatory system resides in a cell lacking thespatial control system exists between - 200 and +120, and yet
this cis-regulatory sequence suffices to produce very accurate
skeletogenic mesenchyme-specific expression.
The SM50 regulatory system and the embryology of
skeletogenic lineage specification
The precursors of the skeletogenic mesenchyme are
autonomously specified, as reviewed in the Introduction. This
is significant in the present context, because an implication of
an autonomous specification process is that the specific gene
expressions that result could be mediated by localized maternal
regulatory factors. The factor binding to element C has now
been isolated by affinity chromatography (which affords the
possibility of securing any co-factors as well), and it will soon
be possible to test this proposition directly. If the factor binding
to element C were indeed localized, or were present in active
form only in the polar region of the egg inherited by the skele-
togenic precursor cells, this would explain the absence of a
negative control system in the SM50 gene. That is, the initial
territorial specification would be spatially confined by cyto-
plasmic localization process(es), rather than by intercellular
signaling across territorial boundaries in the cleavage-stage
embryo. The latter argument would hold whether the localized
factor is a C-element binding transcription factor, a co-factor,
a system that covalently activates these factors, or a factor that
promotes the transcription of a C-element binding transcription
factor or co-factor.
Under various experimental situations other blastomeres
than the precursors of the skeletogenic mesenchyme can be
induced to give rise to mesenchyme cells that secrete skeleton
and express skeletogenic genes such as SM50. Thus isolated
macromeres, which normally give rise only to vegetal plate and
some ectoderm, will differentiate as embryoids that contain
some skeleton (Hörstadius, 1939; Khaner and Wilt, 1991);
animal pole mesomeres, if cultured for several days do thesame (Khaner and Wilt, 1990; Henry et al., 1989); and so do
various combinations of isolated mesomeres and other blas-
tomeres (Khaner and Wilt, 1990). A well known phenomenon
that is particularly germane is the effect of LiCl on isolated
animal pole blastomeres (Livingston and Wilt, 1989; Von
Ubisch, 1929). This agent induces differentiation in prospec-
tive ectoderm cells from the animal half of the embryo of both
skeletogenic mesenchyme and gut, and for the effect to occur,
exposure to LiCl must take place during cleavage, i.e., the
period when blastomere specification is initially occurring.
One interpretation (Davidson, 1989) is that transcription
factors required for skeletogenic gene expression are present
globally but must be activated in order to become functional.
Normally these factors would be presented in active form only
in the skeletogenic mesomeres and their descendants. All the
experimental operations that induce ectopic skeletogenesis
may affect intercell signaling in one way or another, and thus
might result in ectopic activation of a factor such as that
binding to the C element of SM50. However, it is possible that
in none of these experimental situations is there a direct con-
version to skeletogenic fate. Instead the only relevant conver-
sion may be to vegetal plate fate, which in each of theselocator factor and the locator sequence is unoccupied. Enhancers E1
and E2 are present in this cell, but they have no effect on the basal
transcription apparatus, and detectable transcription does not occur.
This would be the case, e.g., in gut or ectoderm cells. Thus the
TFIID-C requires an external additional signal in order to mediate
upstream enhancer functions. In B, the regulatory system is shown in
a cell type of the lineage in which the gene is specified to function,
but at a stage in which the enhancer proteins E1 and E2 are lacking or
inactive. This might be the case, e.g., in skeletogenic precursor cells
prior to the stage in late cleavage when the gene is activated (see
text). The locator sequence is occupied by the locator factor (LF)
which recognizes and binds to its sequence specifically. Either
directly or by means of a co-factor (curved double open arrow) the
locator factor interacts with TAF co-factors of the TFIID complex,
activating them, as symbolized by the specific depressions shown in
their contours. However, in the absence of E1 and E2 there is still no
detectable transcriptional activity. In C, E1 and E2 are present in this
cell lineage, and they interact with the activated TAF co-factors that
are able to service them (specific enhancer factors require different
TAF co-factors, each of which may be able to interact with multiple
enhancer proteins of given structural classes; see e.g., Chen et al.,
1994). This would account for the ability of the activated regulatory
system to respond to a wide range of different enhancer proteins. The
consequence is detectable transcription (solid rightward arrow).
Alternative versions of this model include the possibility that the LF
actually recruits the appropriate TAFs to the TFIID complex; and/or
that the LF interacts with the TFIID complex by means of an adaptor
protein which is the factor that is lineage specific, rather than the
DNA binding LF, as shown here.
1969Cis-regulatory control of the SM50 geneexamples is indeed also known to be induced by the experi-
mental circumstances imposed. The vegetal plate gives rise to
the archenteron and to secondary mesenchyme. When there is
a deficiency of the normal primary skeletogenic mesenchyme,
cells of the secondary mesenchyme are able to transdifferenti-
ate to skeletogenic mesenchyme. This could account for the
appearance of skeletal elements and skeletogenic gene
expression, including SM50 expression, in all of the experi-
mental circumstances that we cite.
Conversion of secondary to skeletogenic mesenchyme fate
at the gastrula stage is a remarkable phenomenon. It can be
induced directly by experimental removal of skeletogenic mes-
enchyme cells (reviewed by Ettensohn and Ingersoll, 1992). A
possible implication is that the SM50 gene must be under some
sort of negative control in the secondary mesenchyme since it
is derepressed in these cells when conversion takes place. On
the surface this is a proposition that runs counter to our
suspicion that the SM50 spatial control system lacks negative
control elements. However, at this late period of embryogene-
sis the presentation of skeletogenic transcription factors almost
certainly depends on their transcription de novo. Therefore it
would be this process that is under negative control in the
secondary mesenchyme.
In summary, we wish to stress the view that detailed func-
tional knowledge of the cis-regulatory systems controlling
spatial gene expression in the embryo will lead immediately to
the generation of an invaluable set of new experimental probes.
These can now be used to illuminate the mechanisms of clas-
sically defined embryological phenomena, in our case the
initial autonomous specification, and the experimentally
induced conditional activation, of skeletogenic cell lineages.
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